The data also revealed that patients with thrombocytopenia (defined as < 150×103/μl and > 0.5 Log2 fold change in platelet count from baseline) had significantly greater NFE2 and PF4 genes downregulation compared to those with normal platelet counts (Figures 4A,B). This evidence concerns the gene NFE2 and Thrombocytopenia.